QT Imaging (NASDAQ:QTI) Stock Gets Price Target Cut from Ladenburg Thalmann & Co. Inc.

QT Imaging (NASDAQ:QTI) had its target price dropped by investment analysts at Ladenburg Thalmann & Co. Inc. to $12.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Ladenburg Thalmann & Co. Inc.‘s target price suggests a potential upside of 465.24% from the stock’s current price.

A number of other equities research analysts have also recently issued reports on QTI. Craig Hallum initiated coverage on QT Imaging in a research note on Monday, October 5th. They issued a “buy” rating and a $8.00 target price on the stock. Weiss Ratings restated a “sell (e+)” rating on shares of QT Imaging in a research report on Tuesday, October 6th. Finally, D. Boral Capital started coverage on shares of QT Imaging in a research note on Friday, October 23rd. They set a “buy” rating and a $9.00 price objective on the stock. Four investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, QT Imaging has an average rating of “Moderate Buy” and a consensus target price of $9.67.

QT Imaging Stock Down 6.1%

QT Imaging stock traded down $0.14 during midday trading on Wednesday, hitting $2.12. The stock had a trading volume of 71,025 shares, compared to its average volume of 41,254. QT Imaging has a 12 month low of $1.96 and a 12 month high of $7.60. The company has a current ratio of 3.10, a quick ratio of 2.06 and a debt-to-equity ratio of 6.81. The stock has a market cap of $29.23 million, a P/E ratio of -1.29 and a beta of 0.05. The business has a fifty day moving average price of $2.47 and a 200 day moving average price of $4.34.

QT Imaging (NASDAQ:QTI) last posted its quarterly earnings results on Tuesday, November 10th. The company reported ($0.02) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.09) by $0.07. QT Imaging had a negative return on equity of 1,202.69% and a negative net margin of 77.25%. The business had revenue of $7.34 million for the quarter, compared to analyst estimates of $10.79 million. Research analysts predict that QT Imaging will post -1.11 EPS for the current year.

Institutional Investors Weigh In On QT Imaging

Several large investors have recently modified their holdings of the stock. Polar Asset Management Partners Inc. acquired a new position in shares of QT Imaging in the 2nd quarter valued at about $210,000. BlackRock Inc. lifted its position in shares of QT Imaging by 116.5% during the 2nd quarter. BlackRock Inc. now owns 61,353 shares of the company’s stock worth $250,000 after purchasing an additional 33,009 shares during the last quarter. Finally, Stonepine Capital Management LLC acquired a new stake in shares of QT Imaging in the second quarter worth $407,000. 24.19% of the stock is owned by institutional investors.

QT Imaging Company Profile

QT Imaging Holdings, Inc. (NASDAQ:QTI) is a medical technology company that develops advanced ultrasound-based imaging systems. Its technology is designed to create three-dimensional images of human tissue without using ionizing radiation. The company’s principal product is the QTscan, an automated breast-imaging system that uses sound waves to capture images without breast compression. The system is intended to support breast imaging and may be particularly relevant for evaluating breast tissue that can be difficult to assess with conventional mammography.